慢性心不全の高齢者の自己軽視に影響を与える要因: 混合方法の研究
Baofeng Zhang1, Shanshan Tang1, Lijuan Zhang1
1Cardiac Rehabilitation Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
まとめ
慢性心不全 (CHF) の高齢者は,独身で生活し,教育レベルが低い,心臓機能が低下し,自己ケアが不足し,家族のサポートが不足しているため,自己軽視する傾向が強い. ターゲットを絞った介入は,彼らの生活の質を向上させることができます.
科学分野:
- ゲロントロジーはゲロントロジーの学科です.
- 心臓病学 心臓病学
- 公衆衛生は公衆衛生である.
背景:
- 自己軽視は,高齢者,特に慢性心不全 (CHF) を患っている人にとって大きな課題です.
- この脆弱な集団における自己軽視に寄与する特定の要因を理解することは,効果的な介入の開発に不可欠です.
研究 の 目的:
- 慢性心不全 (CHF) と診断された高齢者の自己軽視に影響を与える重要な要因を特定し,分析する.
主な方法:
- 定量的な (アンケート) と定性的な (インタビュー) データ収集を組み合わせた説明的な連続混合方法の設計が使用されました.
- データを集めたのは,高齢者の自己怠慢に関するアンケートを使用した466人の患者と,中国の大学病院での非構造的な対面面談を通じて15人の患者です.
主要な成果:
- CHFの高齢者の自己軽視に関連した重要な要因には,低い教育レベル,左心室射出分数の減少,日々の自己ケア能力の低下,生活環境 (ひとり暮らし),不十分な家族のサポートが含まれます.
- 定量分析は,有意な相関を特定し,定性面接は,自己軽視の生きた経験についてより深い洞察を提供しました.
結論:
- 自己軽視を軽減し,CHFの高齢者の生活の質を向上させるための介入は,教育,心臓機能,自己ケア能力,社会的支援,生活状況などの特定された要因に対処するために調整されるべきです.
- 医療従事者は,自己怠慢を軽減し,患者の治療結果を改善するために,これらの標的型戦略を実施する上で重要な役割を果たしています.
関連する概念動画
Heart Failure VII: Nursing Interventions
566
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
566
Pathophysiology of Heart Failure
4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
Heart Failure VI: Adjunct Therapies
428
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
428
Heart Failure I: Introduction
1.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.0K
Heart Failure III: Clinical Manifestations
667
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
667
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
